# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Avinger (NASDAQ:AVGR) reported quarterly losses of $(2.82) per share which missed the analyst consensus estimate of $(0.43) by ...
Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company developing and marketing the first and only intravascula...
Avinger (NASDAQ:AVGR) reported quarterly losses of $(2.49) per share which missed the analyst consensus estimate of $(1.35) by ...